Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Stoke Therapeutics (STOK) Share-based Compensation (2022 - 2025)

Stoke Therapeutics has reported Share-based Compensation over the past 4 years, most recently at $9.8 million for Q4 2025.

  • For Q4 2025, Share-based Compensation rose 37.95% year-over-year to $9.8 million; the TTM value through Dec 2025 reached $32.2 million, up 17.36%, while the annual FY2025 figure was $32.2 million, 17.36% up from the prior year.
  • Share-based Compensation for Q4 2025 was $9.8 million at Stoke Therapeutics, up from $8.0 million in the prior quarter.
  • Over five years, Share-based Compensation peaked at $9.8 million in Q4 2025 and troughed at $5.0 million in Q1 2022.
  • A 4-year average of $6.7 million and a median of $6.7 million in 2023 define the central range for Share-based Compensation.
  • Biggest five-year swings in Share-based Compensation: dropped 8.1% in 2024 and later skyrocketed 37.95% in 2025.
  • Year by year, Share-based Compensation stood at $5.8 million in 2022, then grew by 3.8% to $6.1 million in 2023, then grew by 17.84% to $7.1 million in 2024, then skyrocketed by 37.95% to $9.8 million in 2025.
  • Business Quant data shows Share-based Compensation for STOK at $9.8 million in Q4 2025, $8.0 million in Q3 2025, and $7.6 million in Q2 2025.